GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (FRA:VTFN) » Definitions » Cyclically Adjusted PB Ratio

Vitrolife AB (FRA:VTFN) Cyclically Adjusted PB Ratio : 5.30 (As of Sep. 25, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Cyclically Adjusted PB Ratio?

As of today (2024-09-25), Vitrolife AB's current share price is €20.94. Vitrolife AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 was €3.95. Vitrolife AB's Cyclically Adjusted PB Ratio for today is 5.30.

The historical rank and industry rank for Vitrolife AB's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:VTFN' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 3.34   Med: 23.86   Max: 53.22
Current: 5.32

During the past years, Vitrolife AB's highest Cyclically Adjusted PB Ratio was 53.22. The lowest was 3.34. And the median was 23.86.

FRA:VTFN's Cyclically Adjusted PB Ratio is ranked worse than
79.78% of 455 companies
in the Medical Devices & Instruments industry
Industry Median: 2.14 vs FRA:VTFN: 5.32

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Vitrolife AB's adjusted book value per share data for the three months ended in Jun. 2024 was €8.564. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €3.95 for the trailing ten years ended in Jun. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Vitrolife AB Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Vitrolife AB's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Cyclically Adjusted PB Ratio Chart

Vitrolife AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.21 24.23 40.55 6.72 4.78

Vitrolife AB Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.04 3.87 4.78 4.66 3.82

Competitive Comparison of Vitrolife AB's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Vitrolife AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Vitrolife AB's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Vitrolife AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Vitrolife AB's Cyclically Adjusted PB Ratio falls into.



Vitrolife AB Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Vitrolife AB's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=20.94/3.95
=5.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitrolife AB's Cyclically Adjusted Book per Share for the quarter that ended in Jun. 2024 is calculated as:

For example, Vitrolife AB's adjusted Book Value per Share data for the three months ended in Jun. 2024 was:

Adj_Book=Book Value per Share/CPI of Jun. 2024 (Change)*Current CPI (Jun. 2024)
=8.564/132.7160*132.7160
=8.564

Current CPI (Jun. 2024) = 132.7160.

Vitrolife AB Quarterly Data

Book Value per Share CPI Adj_Book
201409 0.420 100.161 0.557
201412 0.686 100.225 0.908
201503 0.737 99.950 0.979
201506 0.730 99.995 0.969
201509 0.784 100.228 1.038
201512 0.839 100.276 1.110
201603 0.875 100.751 1.153
201606 0.882 101.019 1.159
201609 0.918 101.138 1.205
201612 0.966 102.022 1.257
201703 1.038 102.022 1.350
201706 1.027 102.752 1.326
201709 1.098 103.279 1.411
201712 1.137 103.793 1.454
201803 1.204 103.962 1.537
201806 1.202 104.875 1.521
201809 1.243 105.679 1.561
201812 1.339 105.912 1.678
201903 1.398 105.886 1.752
201906 1.387 106.742 1.725
201909 1.486 107.214 1.839
201912 1.577 107.766 1.942
202003 1.628 106.563 2.028
202006 1.655 107.498 2.043
202009 1.728 107.635 2.131
202012 1.822 108.296 2.233
202103 1.955 108.360 2.394
202106 1.955 108.928 2.382
202109 4.190 110.338 5.040
202112 11.014 112.486 12.995
202203 10.883 114.825 12.579
202206 11.120 118.384 12.466
202209 11.199 122.296 12.153
202212 11.239 126.365 11.804
202303 11.198 127.042 11.698
202306 11.186 129.407 11.472
202309 10.878 130.224 11.086
202312 8.397 131.912 8.448
202403 8.632 132.205 8.665
202406 8.564 132.716 8.564

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Vitrolife AB  (FRA:VTFN) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Vitrolife AB Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Vitrolife AB Business Description

Traded in Other Exchanges
Address
Box 9080, Gothenburg, SWE, 400 92
Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive advanced support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction.

Vitrolife AB Headlines

No Headlines